Miracle Automation Engineering (002009.SZ) plans to sell 7% equity of UQI Intelligent for a price of 130 million yuan.
Tianqi Corporation (002009.SZ) announced that the company intends to acquire 7% of Youqi Intelligence for a consideration of 130 million yuan.
Miracle Automation Engineering (002009.SZ) announced that the company plans to transfer 7% of its equity in Uchi Intelligent for 130 million yuan to UBTECH ROBOTICS Technology, the controlling shareholder of Uchi Intelligent. After the transaction is completed, UBTECH ROBOTICS Technology will directly hold 41.4906% equity in Uchi Intelligent, while the company and its wholly-owned subsidiary Jiangsu Tianqi Borui Intelligent Equipment Development Co., Ltd. (referred to as "Tianqi Borui") will collectively hold 22.4910% equity in Uchi Intelligent, with the company directly holding 16.1596% equity in Uchi Intelligent and Tianqi Borui holding 6.3314% equity in Uchi Intelligent.
The announcement stated that Uchi Intelligent is an important platform for strategic cooperation between the company and UBTECH ROBOTICS Technology. This transaction aims to support the continued acceleration of Uchi Intelligent's development, optimize its shareholder structure and internal governance structure, lay a foundation for its future independent capital operation, further consolidate its sustainable operating capabilities and market competitive advantages.
Related Articles
Crown Advanced Material (688560.SH) terminates investment agreement with CECEP Solar Energy for backsheet and functional film production base project.

Guangdong Zhongsheng Pharmaceutical (002317.SZ): The innovative drug Arlaidevir project has received top-line analysis data results from two Phase III clinical trials.

New stock news | Luku Technology submits application to the Hong Kong Stock Exchange, the shipment volume of vein smart locks in 2024 ranks first in the world.
Crown Advanced Material (688560.SH) terminates investment agreement with CECEP Solar Energy for backsheet and functional film production base project.
Guangdong Zhongsheng Pharmaceutical (002317.SZ): The innovative drug Arlaidevir project has received top-line analysis data results from two Phase III clinical trials.

New stock news | Luku Technology submits application to the Hong Kong Stock Exchange, the shipment volume of vein smart locks in 2024 ranks first in the world.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


